Comparison of Outcomes between HSCT Donor Sources for Pediatric Patients with Hematologic Malignancies
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-126062
Abstract: Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative therapy for pediatric patients with hematologic malignancies. Historically, matched sibling donors (MSD) have been the preferred donor source given ease of availability and lower… read more here.
Keywords: msd mud; donor; dfs; gvhd ... See more keywords